A detailed history of Dsm Capital Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dsm Capital Partners LLC holds 1,720,500 shares of NVO stock, worth $151 Million. This represents 3.18% of its overall portfolio holdings.

Number of Shares
1,720,500
Previous 1,593,921 7.94%
Holding current value
$151 Million
Previous $228 Million 9.96%
% of portfolio
3.18%
Previous 3.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $15.1 Million - $18.4 Million
126,579 Added 7.94%
1,720,500 $205 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $196 Million - $234 Million
1,593,303 Added 257816.02%
1,593,921 $228 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $16,950 - $22,562
166 Added 36.73%
618 $79,000
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $39,676 - $47,663
452 New
452 $46,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dsm Capital Partners LLC Portfolio

Follow Dsm Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsm Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dsm Capital Partners LLC with notifications on news.